Aurora Cannabis (NYSE:ACB,TSX:ACB) announced its Aurora Sky and MedReleaf Bradford facilities are fully licensed by Health Canada.
As quoted in the press release:
“The rapid scale-up of our production capacity – with our Sky and Bradford facilities specifically adding over 128,000 [kilogram] per year in capacity – is resulting in significant increases in product availability across our domestic medical and consumer, as well as our international market segments, over the coming months,” said Terry Booth, CEO of Aurora. “Current production at Aurora Sky, with recent harvests exceeding target yields, validates our production philosophy and our investment in high-tech, highly automated facilities. MedReleaf Bradford employs best practices identified during the integration of the Aurora and MedReleaf organizations, and is consistently delivering exceptional yields and high-quality product that has resonated well in both the medical and consumer markets.”